1-4 of 4
Gerry Oster, PhD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Cost-Effectiveness Of Lenalidomide and Bortezomib In Patients With Previously Untreated Multiple Myeloma (MM)

Gerry Oster, PhD, Ariel Berger, MPH, Rebecca Bornheimer, BA, Gary Binder, MBA, Yasir Nagarwala, MD
Journal: Blood
Blood (2013) 122 (21): 5604.
https://doi.org/10.1182/blood.V122.21.5604.5604
Published: 2013
Journal Articles

Oral Mucositis (OM) and Outcomes of Allogeneic (AL) Hematopoietic Stem Cell Transplantation (HSCT) in Patients with Hematologic Malignancies.

Montserrat Vera-Llonch, MD, MPH, Gerry Oster, PhD, Colleen Ford, John Lu, PhD, Irina Khazanov, Stephen Sonis, DMD, DMSc
Journal: Blood
Blood (2005) 106 (11): 3126.
https://doi.org/10.1182/blood.V106.11.3126.3126
Published: 2005
Journal Articles

Oral Mucositis (OM) and Outcomes of Autologous (AU) Hematopoietic Stem Cell Transplantation (HSCT) Following High-Dose Melphalan (MP) Conditioning for Multiple Myeloma (MM).

Gerry Oster, PhD, Montserrat Vera-Llonch, MD, M.P.H., Colleen Ford, John Lu, MD, Irina Khazanov, Stephen Sonis, DMD, DMSc
Journal: Blood
Blood (2005) 106 (11): 1343.
https://doi.org/10.1182/blood.V106.11.1343.1343
Published: 2005
Journal Articles

Cost of Major Bleeding Following Major Orthopedic Surgery.

Gerry Oster, PhD, Montserrat Vera-Llonch, MD, MPH, May Hagiwara, PhD
Journal: Blood
Blood (2004) 104 (11): 4061.
https://doi.org/10.1182/blood.V104.11.4061.4061
Published: 2004